DFTX Earnings Date: Nov 5, 2026 (Estimated) — Definium Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $37.19
Market Cap $5.0B
P/E -10.4
52W Range $10.46 – $49.70
Next Earnings · After close (est.)

When is DFTX's next earnings date?

Definium Therapeutics, Inc. (DFTX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.56.

How did DFTX do in its last earnings report?

In its most recent report on Aug 6, 2026 (Q2 2026), Definium Therapeutics, Inc. posted EPS of -$1.44 versus the -$0.54 estimate, a miss of 157.1%. Revenue was $0. The stock's 1-day post-earnings move was +0.0%.

How much does DFTX stock move after earnings?

DFTX beat EPS estimates in 3 of its last 8 reported quarters. Over the last 3 reports the stock moved an average of 2.0% (up or down) in the day after earnings.

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-06Q2 2026-0.54-1.44-157.14%$0❌ Miss+0.00%-4.85%-17.45%
2026-05-07Q1 2026-0.49-0.71-44.90%$0❌ Miss-4.96%-7.97%-0.78%
2026-02-26Q4 2025-0.47-0.50-6.38%$0❌ Miss+0.93%+1.50%+3.41%
2022-11-10-0.58-0.56——✅ Beat———
2022-08-11-0.75-0.60——✅ Beat———
2022-05-16-0.75-0.60——✅ Beat———
2022-03-28-0.70-0.75——❌ Miss———
2021-11-12-0.52-0.90——❌ Miss———

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .